Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), the association gathering 28 Taiwan-based, R&D-driven biopharmaceutical companies, highlights the association’s eye-catching initiative to boost international collaboration between academia and the global industry, thanks to the recent set up of the BioIPSeeds® platform, which proudly stands as the first application of blockchain technology in the biopharmaceutical field.
Further bolstering open innovation and an international collaboration culture is particularly high in the agenda of many public and private stakeholders in the healthcare field. What is the contribution of TRPMA to the fulfillment of this important objective?
"Our strategy was to build a completely safe, user-friendly digital platform that would gather together all discoveries and innovation coming from Taiwan’s research centers and universities."
